Global charitable foundation Wellcome has announced a £2.4 million ($3.2 million) investment in a project to track the worldwide impact of superbugs.
The Global Burden of Disease AMR (antimicrobial resistance) project can be to be launched today at the Call to Action conference in Berlin, Germany. Tim Jinks, Wellcome’s head of drug resistant infections, said the idea would likely provide vital information on both the spread as well as impact of drug resistance.
“While we have seen progress in recognition around the globe of the threat of which superbugs pose, we need to regain momentum,” Jinks said. “High-level commitments must quickly become action.”
The problem can be a serious one, with Wellcome saying of which drug resistant infections already kill 700,000 people each year.
The launch comes after Sally Davies, England’s chief medical officer, told the Press Association of which the globe was facing a “dreadful post-antibiotic apocalypse” if action was not taken immediately.
Speaking to the BBC on Friday, Davies reiterated her concerns. “The problem can be of which bacteria become resistant to antibiotics, particularly if they are overused, as well as yet they underpin modern medicine,” she said, explaining of which about 25,000 people across Europe die every year of drug resistant infections.
“I’m actually worried, as are experts, of which if we don’t do things to control This kind of — improve infection prevention, get fresh drugs, better diagnostics — we will risk losing antibiotics,” she said.
The Berlin conference was organized by Wellcome in partnership with the governments of the U.K., Thailand as well as Ghana, as well as the United Nations Foundation.
The AMR project can be a collaboration between the University of Oxford’s Big Data Institute as well as the Institute for Health Metrics as well as Evaluation. the idea can be co-funded by the U.K. government, the Bill as well as Melinda Gates Foundation as well as Wellcome.
“There can be no doubt of which together we can stop the superbugs which could undermine the whole of modern medicine,” Jeremy Farrar, Wellcome’s director, said in a statement Friday. “yet the impact can be today as well as the time to act can be today, we need to bring real urgency to This kind of.”